Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.

The Food and Drug Administration is warning that critical alerts from diabetes devices may fail to reach users, risking ...

BRIDGEWATER, N.J. - Insmed Incorporated (NASDAQ:INSM), a biopharmaceutical company with a market capitalization of $14.57 ...

Once there was a company called AffinityLifeStyles.com. It sold Alkaline Waters – and got into “hot” water. It’s now bankrupt ...

So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period.